Drug: ACTEMRA Injury: Nasopharyngitis Quarter: 2016Q3
Total Records: 92 Number of Pages: 5
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
88351275 | ACTEMRA | Nasopharyngitis | ROCHE | 47.71 YR | M | 55 KG | 20160912 | CA |
90304409 | ACTEMRA | Nasopharyngitis | ROCHE | 42.75 YR | F | 68 KG | 20160808 | CA |
92179805 | ACTEMRA | Nasopharyngitis | ROCHE | 56.47 YR | F | 88 KG | 20160803 | BR |
96650584 | ACTEMRA | Nasopharyngitis | ROCHE | 62.74 YR | M | 110 KG | 20160904 | CA |
98028219 | ACTEMRA | Nasopharyngitis | ROCHE | 67.89 YR | F | 0 | 20160912 | US |
99182488 | ACTEMRA | Nasopharyngitis | ROCHE | 56.33 YR | F | 83 KG | 20160902 | CA |
100941809 | ACTEMRA | Nasopharyngitis | ROCHE | 28.85 YR | F | 60 KG | 20160902 | CA |
104433916 | ACTEMRA | Nasopharyngitis | ROCHE | 67.21 YR | M | 89 KG | 20160826 | CA |
105290178 | ACTEMRA | Nasopharyngitis | SYMPLMED PHARMACEUTICALS | 0.00 | 0 | 20160727 | CA | |
105531773 | ACTEMRA | Nasopharyngitis | ROCHE | 0.00 | F | 0 | 20160819 | CA |
107539586 | ACTEMRA | Nasopharyngitis | ROCHE | 44.10 YR | F | 0 | 20160920 | CA |
110201958 | ACTEMRA | Nasopharyngitis | ROCHE | 46.87 YR | F | 72 KG | 20160726 | CA |
110427987 | ACTEMRA | Nasopharyngitis | ROCHE | 58.77 YR | F | 47 KG | 20160729 | BR |
111242825 | ACTEMRA | Nasopharyngitis | ROCHE | 62.85 YR | F | 85 KG | 20160907 | CA |
113599499 | ACTEMRA | Nasopharyngitis | ROCHE | 77.69 YR | F | 49 KG | 20160919 | CA |
114444528 | ACTEMRA | Nasopharyngitis | ROCHE | 54.63 YR | F | 0 | 20160912 | CA |
114649554 | ACTEMRA | Nasopharyngitis | ROCHE | 32.73 YR | F | 59 KG | 20160912 | CA |
115807306 | ACTEMRA | Nasopharyngitis | ROCHE | 0.00 | F | 93 KG | 20160901 | CA |
115950735 | ACTEMRA | Nasopharyngitis | AMGEN | 33.00 YR | F | 0 | 20160715 | CA |
116314048 | ACTEMRA | Nasopharyngitis | ROCHE | 0.00 | F | 0 | 20160908 | CA |
Total Records: 92 Number of Pages: 5